NASDAQ: ABCL · Biotechnology
Over the past week, AbCellera Biologics (ABCL) pulled in about 58 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 55% bullish but is far apart: News runs 100% bullish while Reddit sits at just 22%. Wall Street is more constructive, with 9 of 9 analysts rating ABCL a buy.
There is little buzz around ABCL this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 22% to News at 100%. No other tracker puts the two side by side.
Across 9 analysts the consensus is a Strong Buy: 9 buy calls against 0 sell, with an average 12-month price target of $17.12.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 45 points above the crowd average of 55%, the professionals are more constructive than retail. The split is inside the crowd: News reads 100% bullish while Reddit sits at 22%, a 78-point spread that single-source trackers miss.
Over the 30-day window, AbCellera Biologics (ABCL) buzz held elevated around 60.1 while the price drifted down 0.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 6.4M shares. Over the last 7 trading days, ABCL lost 4.1%. Buzz activity in the recent week averaged 46.7 and was variable, swinging between 35.1 and 60.1. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 20 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ABCL and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABCL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (9 / 0 / 0) |
| Crowd bullish (7d) | 55% |
| Avg price target | $17.12 |
| Most bullish source | News, 100% |
| Most bearish source | Reddit, 22% |
| Sentiment spread | 78 pts |
| Mentions (7d) | 58 |
| Market cap | $3.39B |
| P/E · Forward P/E | n/a · 27.6 |
| EPS · Beta | -$0.51 · 1.3 |
| Revenue (TTM) | $66.2M · -249% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, AbCellera Biologics (ABCL) currently carries an Adanos hold signal with 61/100 conviction. The current cross-source average reads 55% bullish across 3 active sources. Those sources contribute 58 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around AbCellera Biologics (ABCL) is fairly quiet with 9 mentions over the last 7 days; the 30-day context spans 13 tracked subreddits. The 7-day tone is 22% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads split on AbCellera Biologics (ABCL), averaging 55% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 100% bullish and Reddit at 22%, a 78-point spread. On the professional side, 9 of 9 analysts rate ABCL a buy.
Of the 9 analysts covering AbCellera Biologics (ABCL), 9 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $17.12. That puts the street ahead of the crowd, which averages 55% bullish.
AbCellera Biologics (ABCL)'s cross-source average is mixed at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 42% bullish, News reads 100% bullish and reddit coverage is the most negative at 22% bullish. The combined signal points to broad mixed pressure with 61/100 conviction.
The cross-source average is mixed for AbCellera Biologics (ABCL) at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 22% bullish. 3-day activity momentum is falling on Reddit, while x activity is rising. The hold signal carries 61/100 conviction.
X is the dominant discussion channel with 47 mentions (81% of total volume). Reddit contributes 9 mentions and News contributes 2 mentions. The cross-source average is mixed at 55% bullish, while x is the only source with rising 3-day activity. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABCL's hold signal at 61/100 conviction reflects a mixed cross-source average at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The ABCL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key